Fremont, CA – DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced the launch of the KILR Retroparticles product line, providing scientists complete flexibility to develop a simple cytotoxicity assay in almost any cell line. Recent advances in the development of cancer immunotherapies using either bi-specific antibody […]
Venlo, The Netherlands, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced that it has decided to submit a conditional voluntary takeover offer to the shareholders of Exiqon A/S (NASDAQ OMX Copenhagen: EXQ) to purchase all shares in Exiqon. The acquisition is expected to expand QIAGEN’s leadership position in Sample to Insight solutions for […]
Copenhagen, – Exiqon A/S (Nasdaq Copenhagen: “EXQ”) announced that QIAGEN N.V (“QIAGEN”) has informed the Company that it will submit a voluntary conditional public takeover offer to buy the entire share capital of Exiqon A/S for DKK 18 per share of nominal DKK 1.00 (‘Offer Price’). This will be documented by an Offer Document, which […]
Fremont, CA – March 29, 2016 – DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced the launch of the KILR Retroparticles product line, providing scientists complete flexibility to develop a simple cytotoxicity assay in almost any cell line. Recent advances in the development of cancer immunotherapies […]
WALTHAM, Mass. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, issued the following statement regarding Affymetrix, Inc.’s (NASDAQ: AFFX) press release dated March 28, 2016: JP Morgan is acting as financial advisor to Thermo Fisher, and Wachtell, Lipton, Rosen & Katz is serving as legal counsel.“We are pleased that the […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or “the Company”) today announced that the Company’s Board of Directors (the “Board”), in consultation with its legal and financial advisors, has determined that the unsolicited merger proposal submitted by Origin Technologies Corporation, LLC (“Origin”) on March 22, 2016 does not constitute a Superior Proposal, as […]
BROOMFIELD, CO – ViroCyt®, the leader in rapid virus quantification, announced that it has developed and launched an antibody-based detection system for influenza capable of determining virus titer for both flu A and flu B during a one minute analysis. Every year, the flu virus causes millions of cases of illness and hundreds of thousands […]
AMSBIO announces an extensive range of primary human cancer cells obtained directly from a variety tumor types, including breast, colon and prostate. Despite significant advances in cancer research and treatments, the eradication of the disease remains elusive. This has led to a more urgent focus on precision medicine and advanced treatments like immunotherapy and the […]
Newark, California — DNA2.0, Inc., the leading California-based bioengineering company, announced today that it has moved its corporate headquarters from Menlo Park, CA to a new, energy efficient, environmentally friendly bioproduction facility in Newark, CA, right across the San Francisco Bay from its prior location. “Over the last few years, DNA2.0 has experienced significant business […]
Cambridge, UK, – Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), the leading international gene editing company supplying tools and services that power genomics research and the development of personalized medicines announces the launch of HDx FFPE RNA Fusion Reference Standards, independent analytical controls for the optimization and validation of targeted RNA-seq, endpoint […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
